These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 19632348)

  • 1. Spermine improves recognition memory deficit in a rodent model of Huntington's disease.
    Velloso NA; Dalmolin GD; Gomes GM; Rubin MA; Canas PM; Cunha RA; Mello CF
    Neurobiol Learn Mem; 2009 Nov; 92(4):574-80. PubMed ID: 19632348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quinolinic acid released from polymeric brain implants causes behavioral and neuroanatomical alterations in a rodent model of Huntington's disease.
    Haik KL; Shear DA; Schroeder U; Sabel BA; Dunbar GL
    Exp Neurol; 2000 Jun; 163(2):430-9. PubMed ID: 10833318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progressive behavioural changes in the spatial open-field in the quinolinic acid rat model of Huntington's disease.
    Scattoni ML; Valanzano A; Popoli P; Pezzola A; Reggio R; Calamandrei G
    Behav Brain Res; 2004 Jul; 152(2):375-83. PubMed ID: 15196806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenosine A2A receptor blockade before striatal excitotoxic lesions prevents long term behavioural disturbances in the quinolinic rat model of Huntington's disease.
    Scattoni ML; Valanzano A; Pezzola A; March ZD; Fusco FR; Popoli P; Calamandrei G
    Behav Brain Res; 2007 Jan; 176(2):216-21. PubMed ID: 17123640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spermine attenuates behavioral and biochemical alterations induced by quinolinic acid in the striatum of rats.
    Velloso NA; Dalmolin GD; Fonini G; Gindri Sinhorin VD; Ferreira da Silveira A; Rubin MA; Mello CF
    Brain Res; 2008 Mar; 1198():107-14. PubMed ID: 18243165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The IGF-I amino-terminal tripeptide glycine-proline-glutamate (GPE) is neuroprotective to striatum in the quinolinic acid lesion animal model of Huntington's disease.
    Alexi T; Hughes PE; van Roon-Mom WM; Faull RL; Williams CE; Clark RG; Gluckman PD
    Exp Neurol; 1999 Sep; 159(1):84-97. PubMed ID: 10486177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-term lithium treatment promotes neuronal survival and proliferation in rat striatum infused with quinolinic acid, an excitotoxic model of Huntington's disease.
    Senatorov VV; Ren M; Kanai H; Wei H; Chuang DM
    Mol Psychiatry; 2004 Apr; 9(4):371-85. PubMed ID: 14702090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Behavior characterization of a model of Huntington's disease in rats, induced by quinolinic acid].
    Francis L; Cruz R; Antúnez I; Rosillo JC
    Rev Neurol; 2000 Jun 1-15; 30(11):1016-21. PubMed ID: 10904945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spermine reverses lipopolysaccharide-induced memory deficit in mice.
    Frühauf PK; Ineu RP; Tomazi L; Duarte T; Mello CF; Rubin MA
    J Neuroinflammation; 2015 Jan; 12():3. PubMed ID: 25573647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. D-Serine and a glycine transporter inhibitor improve MK-801-induced cognitive deficits in a novel object recognition test in rats.
    Karasawa J; Hashimoto K; Chaki S
    Behav Brain Res; 2008 Jan; 186(1):78-83. PubMed ID: 17854919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormalities of somatosensory evoked potentials in the quinolinic acid model of Huntington's disease: evidence that basal ganglia modulate sensory cortical input.
    Schwarz M; Block F; Töpper R; Sontag KH; Noth J
    Ann Neurol; 1992 Sep; 32(3):358-64. PubMed ID: 1329611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Memantine reduces oxidative damage and enhances long-term recognition memory in aged rats.
    Pietá Dias C; Martins de Lima MN; Presti-Torres J; Dornelles A; Garcia VA; Siciliani Scalco F; Rewsaat Guimarães M; Constantino L; Budni P; Dal-Pizzol F; Schröder N
    Neuroscience; 2007 Jun; 146(4):1719-25. PubMed ID: 17445991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amelioration of behavioral deficits in a rat model of Huntington's disease by an excitotoxic lesion to the globus pallidus.
    Ayalon L; Doron R; Weiner I; Joel D
    Exp Neurol; 2004 Mar; 186(1):46-58. PubMed ID: 14980809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blockade of quinolinic acid-induced neurotoxicity by pyruvate is associated with inhibition of glial activation in a model of Huntington's disease.
    Ryu JK; Kim SU; McLarnon JG
    Exp Neurol; 2004 May; 187(1):150-9. PubMed ID: 15081596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tiagabine, a GABA uptake inhibitor, attenuates 3-nitropropionic acid-induced alterations in various behavioral and biochemical parameters in rats.
    Dhir A; Akula KK; Kulkarni SK
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):835-43. PubMed ID: 18234412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Galantamine reduces striatal degeneration in 3-nitropropionic acid model of Huntington's disease.
    Park JE; Lee ST; Im WS; Chu K; Kim M
    Neurosci Lett; 2008 Dec; 448(1):143-7. PubMed ID: 18938211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bilateral quinolinic acid-induced lipid peroxidation, decreased striatal monoamine levels and neurobehavioral deficits are ameliorated by GIP receptor agonist D-Ala
    Verma MK; Goel R; Nandakumar K; Nemmani KVS
    Eur J Pharmacol; 2018 Jun; 828():31-41. PubMed ID: 29577894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deficits induced by quinolinic acid lesion to the striatum in a position discrimination and reversal task are ameliorated by permanent and temporary lesion to the globus pallidus: a potential novel treatment in a rat model of Huntington's disease.
    Joel D; Ayalon L; Tarrasch R; Weiner I
    Mov Disord; 2003 Dec; 18(12):1499-507. PubMed ID: 14673887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic administration of quinolinic acid in the rat striatum causes spatial learning deficits in a radial arm water maze task.
    Shear DA; Dong J; Haik-Creguer KL; Bazzett TJ; Albin RL; Dunbar GL
    Exp Neurol; 1998 Apr; 150(2):305-11. PubMed ID: 9527900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Replication of the neurochemical characteristics of Huntington's disease by quinolinic acid.
    Beal MF; Kowall NW; Ellison DW; Mazurek MF; Swartz KJ; Martin JB
    Nature; 1986 May 8-14; 321(6066):168-71. PubMed ID: 2422561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.